Evolent Health Down over 14%, on Pace for Largest Percent Decrease Since November 2025

Dow Jones07-24

Evolent Health Inc Class A (EVH) is currently at $4.76, down $0.81 or 14.45%

 

--Would be lowest close since June 22, 2026, when it closed at $4.48

--On pace for largest percent decrease since Nov. 7, 2025,when it fell 17.33%

--Currently down three consecutive days; down 19.65% over this period

--Worst three day stretch since the three days ending Nov. 10, 2025, when it fell 22.05%

--Down 12.08% month-to-date; on pace for worst month since March 2026, when it fell 29.85%

--Up 19.12% year-to-date

--Down 88.01% from its all-time closing high of $39.74 on Sept. 12, 2022

--Down 49.04% from 52 weeks ago (July 24, 2025), when it closed at $9.35

--Down 52.59% from its 52-week closing high of $10.05 on July 31, 2025

--Up 119.59% from its 52-week closing low of $2.17 on March 30, 2026

--Traded as low as $4.72; lowest intraday level since June 23, 2026, when it hit $4.43

--Down 15.35% at today's intraday low; largest intraday percent decrease since Nov. 7, 2025, when it fell as much as 17.94%

 

All data as of 1:30:09 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 23, 2026 13:33 ET (17:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment